Summary
Eli Lilly's new obesity medication, ritatratide, shows promising results in clinical trials, demonstrating the potential to double weight loss compared to the highest dose of Ozempic. According to obesity specialist Professor Donal O'Shea, participants in the ritatratide group lost an average of 20 kilograms, while those on Ozempic lost about 10 kilograms. Both groups exhibited similar improvements in diabetes control, indicating that ritatratide may offer enhanced benefits for individuals managing both obesity and diabetes.
The drug is currently undergoing phase three trials, which are necessary for regulatory approval before it can be marketed. O'Shea notes that while ritatratide is not yet officially available, it is being misused in the aesthetics industry and sold on the black market. He anticipates that a trade name and official release could occur by the end of next year, starting in the United States before expanding to the UK and Europe.
O'Shea emphasizes that these developments signal the dawn of a new era in obesity treatment, moving away from decades of ineffective options. He expresses optimism about the future of obesity management, suggesting that ritatratide could significantly outperform existing treatments like Ozempic, which is set to be withdrawn by 2028.
Show Notes
Eli Lilly’s next generation weight loss drug, known as retatrutide, was shown to provide more than double the weight loss of Ozempic’s highest dose, according to new clinical trial results. Professor Donal O'Shea, Anti-Obesity Specialist on the results of this study. See omnystudio.com/listener for privacy information.
More from News at One
Evidence of human activity dating back some 9,000 years has been uncovered in Wicklow for the first time in the County. An archaeological dig near Blessington discovered a number of artefacts buried in a charcoal pit on the site of the Threecastles Solar Farm. Archaeologist Laurence Dunne tells us exactly what they dug up.
Numbers from the Irish Nurses and Midwives Organisation showed 840 patients waiting on trolleys yesterday. Dr John Cronin, president of the Irish Association for Emergency Medicine, on why hospitals are facing a trolley crisis. See omnystudio.com/listener for privacy information.
U2 has released the details of their upcoming European and UK tour, but with no Irish dates! For the latest, Ken Sweeney, Showbiz Editor of the Irish Sun.
Over the past 12 months there have been 38,589 homes built in Ireland. New CSO figures show just over a 10% increase then the same time last year. Our reporter Cara McHugh gets reaction from people in Dublin about housing and our Economics and Public Affairs Editor, David Murphy tells us more about the figures.
The train crash has claimed the lives of 69 people, Spanish police say work to identify victims is still ongoing. Freelance Journalist Simon Hunter spoke to Cian from Spain.